83 studies found for:    "factor V Leiden thrombophilia" OR "Thrombophilia"
Show Display Options
Rank Status Study
21 Recruiting ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
Conditions: Graft Patency;   Coronary Artery Bypass Grafting Surgery;   Hypercoagulability;   Thrombosis
Interventions: Drug: Clopidogrel+acetylsalicylic acid;   Drug: acetylsalicylic acid
22 Unknown  Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Condition: Cancer
Intervention:
23 Completed Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
Condition: Deep Venous Thrombosis
Intervention:
24 Terminated Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Conditions: Venous Thromboembolism;   Fetal Death
Intervention: Other: Thrombophilia Testing
25 Completed Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
Conditions: Pregnancy;   Iron Deficiency;   Iron Deficiency Anemia
Interventions: Dietary Supplement: Lattoglobina (Grunenthal) containing bLf;   Drug: FerroGrad by Abbott
26 Completed Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?
Condition: Chest Pain
Intervention:
27 Completed Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
Conditions: Venous Thrombosis;   Venous Insufficiency
Intervention:
28 Completed Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test
Conditions: Factor V Leiden;   Factor II;   Thrombosis
Intervention:
29 Recruiting Low Weight Heparin prOphylaxis for Placental‐Mediated Complications of PrEgnancy
Conditions: High Risk Pregnant Women;   Placental Insufficiency;   Preeclampsia
Intervention: Drug: Enoxaparin
30 Terminated Thrombin Generation and Thromboelastography in Non-overt DIC
Conditions: Sepsis;   Disseminated Intravascular Coagulation
Intervention:
31 Withdrawn Study to Look at the Effects of ART-123 on Patients With Sepsis and Disseminated Intravascular Coagulation (DIC)
Conditions: Disseminated Intravascular Coagulation;   Sepsis
Interventions: Drug: ART-123;   Drug: placebo
32 Withdrawn Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Drug: Rituximab
33 Completed Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND
Condition: Protein C Deficiency
Intervention: Drug: Protein C Concentrate (Human) Vapor Heated
34 Terminated Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
Condition: Disseminated Intravascular Coagulation
Intervention: Drug: antithrombin alfa (INN name)
35 Not yet recruiting Atenativ Effect on Uterine Blood Flow and Preeclampsia
Condition: Antithrombin III Deficiency
Intervention: Drug: Atenativ
36 Terminated A Phase 3 Clinical Study of KW-3357 in Patients With DIC
Condition: Disseminated Intravascular Coagulation (DIC)
Intervention: Drug: KW-3357
37 Completed A Clinical Study of KW-3357 in Patients With DIC
Condition: Disseminated Intravascular Coagulation (DIC)
Intervention: Drug: KW-3357
38 Completed Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Biological: anti-vWF Nanobody;   Biological: Placebo
39 Withdrawn The Plasma Large-Volume Exchange RCT
Conditions: Purpura, Thrombotic Thrombocytopenic;   Hemolytic Uremic Syndrome
Intervention: Procedure: Plasma Exchange
40 Completed An Open-label Study of KW-3357
Condition: Disseminated Intravascular Coagulation (DIC)
Interventions: Drug: KW-3357;   Drug: Plasma-derived antithrombin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years